CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Free “LabXchange” Science Education Accelerator Launched By the Amgen Foundation And Faculty of Arts and Sciences at Harvard

admin - 0
Latest Pharma-News

US FDA grants priority review of GlaxoSmithKline’s belantamab mafodotin for patients with relapsed or refractory multiple myeloma

admin - 0
Latest Pharma-News

The U.S.FDA approved Horizon Therapeutics Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease

admin - 0
Latest Pharma-News

Supernus Announces U.S. FDA Acceptance for Review of the New Drug Application for SPN-812 for the Treatment of ADHD

admin - 0
Latest Pharma-News

The European Commission (EC) approved Novartis Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease

admin - 0
Latest Pharma-News

AstraZeneca’s Imfinzi and tremelimumab granted Orphan Drug Designation in the US for the treatment of hepatocellular carcinoma

admin - 0
Latest Pharma-News

Heroic-Faith Medical Science expects US FDA clearance for AI-powered respiratory monitor

admin - 0
Latest Pharma-News

WuXi Biologics and Bayer jointly Enter into an Acquisition Agreement on a Drug Product Plant in Germany

admin - 0
Latest Pharma-News

TG Therapeutics Initiates Rolling Submission of NDA to U.S. FDA for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma or...

admin - 0
Latest Pharma-News

FDA Grants Fast Track Designation to Arena Pharmaceuticals’ APD418 for Development for the treatment Decompensated Heart Failure Patients

admin - 0
Latest Pharma-News

The U.S. FDA is alertes safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

admin - 0
Latest Pharma-News

Bristol-Myers Squibb Company announced U.S. FDA accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line...

admin - 0
1...132133134...145Page 133 of 145
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved